Understanding FDA's Recall Authority and Policy

This course will teach how to establish a roadmap for conducting recalls. The knowledge you gain will sharpen your recall management decisions and strategy. You will learn how to use the FDA's health risk criteria so you can develop effective recall procedures. One critical aspect of recalls involves the identification of the root cause of the recall and how you could or should prevent that problem from happening again. Your corrective and preventive action program (CAPA) and quality assurance functions require a rigorous approach to prevent a chronic history of recalls. Reiterative recalls lead the FDA to the conclusion that, "You don't get it." FDA's recall authority and program launches you into a project of crisis management.

Your compliance competency becomes a regulatory issue for the FDA if your recall is deemed ineffective. The seminar will cover critical performance targets for conducting an effective recall. You will learn how missteps in the recall process become an expensive problem in terms of money and a sloppy corporate image.

You will take away practical knowledge on how to work with FDA staff during a recall, and how you can prepare for inspectional follow up or a regulatory action, and in some cases a legal action. You will learn that your approach to recalls plays a major role in mitigating direct and indirect damage to your firm's business. A firm with a history of chronic recalls needs to learn how to get out of that downward spiral. Likewise, for established and new firms you will learn how you can reduce the negative impact of a recall with the use of proper planning.

Learning Objectives:

  • Understand FDA's recall authority and policy
  • Learn how to manage recalls under FDA oversight
  • Learn how to interact with FDA
  • See how to develop health risk determinations
  • Learn critical recall strategy components
  • Manage possible FDA enforcement actions

Who will Benefit:

  • Recall managers
  • Quality assurance managers
  • Regulatory affairs directors
  • Risk and product liability managers
  • Manufacturers’ sales and marketing managers
  • Own label distributors

Companies and departments:

  • Manufacturers
  • Own Label Distributors
  • Importers
  • Healthcare institutions
  • Nursing homes
  • Medical practice groups

Agenda

DAY 01(10:00 AM to 16:00 PM)

Day 1 - Morning

FDA’s Regulatory Authority

  • Recall Regulations
  • Voluntary recall: 21 Code of Federal Regulations (C.F.R.) Part 7
  • Mandatory recall actions
  • 21 C.F.R. Part 810
  • 21 C.F.R. Part 806

Recall Classification

  • Violation of the law
  • Risk to Health
  • Precedents
  • Exemptions
  • Stock Recovery
  • Product Withdrawal
  • Product Improvement

Recalls and risk to health

  • Risk to health categories
  • Death
  • Serious injury / serious illness
  • Non-reversible / reversible
  • May cause, if it were to recur
  • Remote possibility
  • Health Hazard Evaluation for Recall Classification
  • FDA’s internal evaluation
  • Vulnerable subpopulations
  • Scoring
  • Participants
  • Industry HHE equivalent
  • FDA’s recall database
DAY 02(10:00 AM to 16:00 PM )

Day 2 - Morning

FDA’s Recall Procedures

  • Understanding FDA’s program and implementation
  • FDA’s agency-wide recall procedures
  • The FDA’s investigator’s job
  • Preparing a recall strategy
  • Preparing for FDA oversight
  • Recall notification to FDA’s District Office
  • Recall notification to the public
  • Root cause identification
  • Correction and Prevent Action (CAPA)

FDA inspectional follow up

Enforcement: FDA administrative and legal remedies

End

Topic Background:

The products regulated by the FDA can cause serious adverse health consequences or death. The FDA's recall program is designed to make sure firms' recalls can mitigate such problems, even when the adverse consequence seems remote. The FDA's recall program has remained relatively the same over several years. How the FDA and industry manage recalls and learn from their mistakes continues to evolve. In some ways recalls have become more efficient through the benefit of technology. In other ways the reason for recalls remains substantially the same. The FDA's recall procedures and regulatory management of any risk to health are still sufficient to determine whether a recall is effective and whether manufacturers learn from their mistakes.

Choose a Purchase Options


€1.295

Early Bird One Dial-in One Attendee - Live + 90 days Access

2 Days Virtual Seminar Registration After 31 July EUR 1985

You get one log-in for the live virtual seminar for one participant, presentation materials , Certificate and the opportunity to ask questions by phone and email. Recorded Access for 90 days is included.

€1.296

Recorded Access Single Participant

2 Days Virtual Seminar

You'll have 12 month access to single log-in for an archived recording of the entire 2 day virtual seminar including the Q&A period. You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately 48 hours after the session

€3.995

Group-Max. 10 Attendees - Live + 12 month Access

2 Days Virtual Seminar

You get Group log-in for the live virtual seminar for 10 participants, presentation materials , Certificate and the opportunity to ask questions by phone and email. On Demand Recorded Access is Included for 12 month for the Group.

€3.998

Recorded Access Group-Max. 10 Attendees

2 Days Virtual Seminar

You'll have 12 month access to group log-in upto 10 attendees for an archived recording of the entire 2 day virtual seminar including the Q&A period. You can log in any time of day or night. You'll also receive all presentation materials, plus an audio recording and transcript for the entire session. Delivery is approximately 48 hours after the session



Kelly Thomas FDA Trainer

Kelly Thomas (25+ year exp.)

Vice President, Americas Quality Operations at Stallergenes Greer - Charlotte Metro USA

Ms. Thomas has over two decades of cGMP hands-on industry experience in both pharmaceutical and medical device manufacturing operations. Her experience covers all Quality Systems; as well as, all areas of validation; including, process/product validation, facilities validation, CSV and 21 CFR Part 11, test method validation, equipment/automated processes and cleaning validation.